Short-acting inhaled bronchodilators for cystic fibrosis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate short-acting inhaled bronchodilators in children and adults with CF in terms of clinical outcomes and safety.

This is a protocol.